Home Tuberculosis Point-of-Care Diagnostics Market for Infectious Diseases by Indication, Type of Technology and...

Point-of-Care Diagnostics Market for Infectious Diseases by Indication, Type of Technology and Geography – Global Industry Trends and Forecasts, 2020-2030 – ResearchAndMarkets.com

45
0

DUBLIN–()–The “Point-of-Care Diagnostics Market for Infectious Diseases by Indication, Type of Technology and Geography: Industry Trends and Global Forecasts, 2020-2030” report has been added to ResearchAndMarkets.com’s offering.

The ‘Point-of-Care Diagnostics Market for Infectious Diseases, 2020-2025’ report features an extensive study on point-of-care diagnostics that are either commercialized or are under development for diagnosis of different types of infections. In addition, it features an elaborate discussion on the likely future opportunity associated with such tools, over the next five years.

One of the key objectives of the report was to estimate the existing market size and potential future growth opportunities. Based on various parameters, such as number of available / under development products, average price of point-of-care tests and estimated annual adoption rates, we have provided an informed estimate on the likely evolution of the market over the period 2020-2025.

The report also features the likely distribution of the current and forecasted opportunity across [A] target disease indications (chikungunya, COVID-19, dengue, Ebola, hepatitis, HIV/AIDS, influenza, malaria, pneumonia, tuberculosis, and zika), [B] type of technology (lateral flow, molecular diagnostics, fluorescence immunoassay, solid phase, and others), and [C] key geographical regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World).

In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.

Key Questions Answered

  • What are the prevalent trends within the point-of-care diagnostics market?
  • What are the key technologies being used in point-of-care diagnostics?
  • Who are the leading developers of point-of-care diagnostics for COVID-19?
  • Who are the leading developers of point-of-care diagnostics for tropical diseases (chikungunya, dengue, Ebola, malaria, and Zika) and respiratory infections (influenza, pneumonia, and tuberculosis)?
  • Who are the leading developers of point-of-care diagnostics for HIV/AIDS and hepatitis?
  • Which partnership models are commonly adopted by stakeholders in this industry?
  • How is the current and future market opportunity likely to be distributed across key market segments and geographical regions?

Key Topics Covered:

1. PREFACE

1.1. Scope of the Report

1.2. Research Methodology

1.3. Key Questions Answered

1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview

3.2. Overview of Point-of-Care Diagnostics (POCDs)

3.3. Challenges Associated with Point-of-Care Diagnostics

3.4. Future Perspectives

4. CURRENT MARKET LANDSCAPE (FOCUS ON COVID-19)

4.1. Chapter Overview

4.2. Point-of-Care Diagnostics for COVID-19: List of Products

4.3. Point-of-Care Diagnostics for COVID-19: List of Developers

5. CURRENT MARKET LANDSCAPE (FOCUS ON TROPICAL DISEASES)

5.1. Chapter Overview

5.2. Point-of-Care Diagnostics for Tropical Diseases: List of Products

5.3. Point-of-Care Diagnostics for Tropical Diseases: List of Developers

6. CURRENT MARKET LANDSCAPE (FOCUS ON RESPIRATORY INFECTIONS)

6.1. Chapter Overview

6.2. Point-of-Care Diagnostics for Respiratory Infections: List of Products

6.3. Point-of-Care Diagnostics for Respiratory Infections: List of Developers

7. CURRENT MARKET LANDSCAPE (FOCUS ON HIV/AIDS AND HEPATITIS)

7.1. Chapter Overview

7.2. Point-of-Care Diagnostics for HIV/AIDS and Hepatitis: List of Products

7.3. Point-of-Care Diagnostics for HIV/AIDS and Hepatitis: List of Developers

8. OVERALL MARKET LANDSCAPE

8.1. Chapter Overview

8.2. Analysis by Type of Technology

8.3. Analysis by Target Disease Indication

8.4. Analysis by Sensitivity Range

8.5. Analysis by Specificity Range

8.6. Analysis by Turnaround Time

9. PARTNERSHIPS AND COLLABORATIONS

9.1. Chapter Overview

9.2. Partnership Models

9.3. Point-of-Care Diagnostics for Infectious Diseases: List of Partnerships and Collaborations

10. KEY ACQUISITION TARGETS

10.1. Chapter Overview

10.2. Scope and Methodology

10.3. Scoring Criteria and Key Assumptions

10.4. Potential Strategic Acquisition Targets in North America

10.5. Potential Strategic Acquisition Targets in Europe

10.6. Potential Strategic Acquisition Targets in Asia-Pacific

10.7. Potential Strategic Acquisition Targets in Latin America

10.8. Potential Strategic Acquisition Targets in Middle East, North Africa, and Rest of the World

10.9. Concluding Remarks

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS

11.1. Chapter Overview

11.2. Forecast Methodology and Key Assumptions

11.3. Global Point-of-Care Diagnostics for Infectious Diseases Market, 2020-2025

11.4. Global Point-of-Care Diagnostics for Infectious Diseases Market, 2020 and 2025: Distribution by Target Disease Indication

11.5. Global Point-of-Care Diagnostics for Infectious Diseases Market, 2020 and 2025: Distribution by Type of Technology

12. EXECUTIVE INSIGHTS

12.1. Chapter Overview

12.2. Proactive Diagnostics

12.3. UrSure

12.4. Accurex Biomedical

12.5. Hemex Health

12.6. Credo Diagnostics Biomedical

13. CONCLUDING REMARKS

14. APPENDIX 1: TABULATED DATA

For more information about this report visit https://www.researchandmarkets.com/r/cfiypp

https://www.businesswire.com/news/home/20210105005696/en/Point-of-Care-Diagnostics-Market-for-Infectious-Diseases-by-Indication-Type-of-Technology-and-Geography—Global-Industry-Trends-and-Forecasts-2020-2030—ResearchAndMarkets.com

This site uses Akismet to reduce spam. Learn how your comment data is processed.